The latest research study “Cannula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global cannula market share reached US$ 138.7 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 206.6 Million by 2027, exhibiting a CAGR of 7.4% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download free sample brochure: https://www.imarcgroup.com/cannula-market/requestsample
Industry Definition and Application:
A cannula refers to a small hollow tube with a retractable and sharp inner core that is inserted into an artery, vein, or body for administering medication and drawing off fluids. It is available in several product variants, including cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas, etc. Cannula tubes are extensively used for injecting fillers as it reduces the risk of bleeding and bruising, cause lesser pain, and provide greater flexibility as compared to hypodermic needles. Consequently, they find widespread applications across numerous segments of the healthcare sector, such as hospitals, blood banks, Ambulatory Surgery Centers (ASCs), laboratories, pathology labs, etc.
Cannula Market Industry Trends and Drivers:
The growing prevalence of chronic diseases, including cardiovascular illnesses, diabetes, obesity, etc., and the elevating number of surgical procedures being performed around the world, are primarily driving the cannula market. Additionally, the expanding geriatric population, and the escalating inclination toward minimally invasive surgeries (MIS) that ensure less surgical trauma, minimized infection risks, and smaller scars are further stimulating the market growth. Moreover, the rising popularity of cosmetic surgeries is acting as another significant growth-inducing factor. Apart from this, the increasing advancements in healthcare facilities in the emerging nations and the inflating investment undertaken by leading vendors in research and development (R&D) activities for introducing advanced products such as a bidirectional arterial cannula to reduce the risk of limb ischemia are expected to propel the cannula market over the forecasted period.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/cannula-market
Companies Covered
Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated and Terumo Corporation
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Product:
- Cardiac Cannulas
- Nasal Cannulas
- Vascular Cannulas
- Dermatology Cannulas
- Arthroscopy Cannulas
- Others
Cardiac cannulas currently represent the largest market segment due to the growing global population and the rising prevalence of cardiovascular diseases across the globe.
Breakup by Type:
- Neonatal Cannulas
- Straight Cannulas
- Winged Cannula
- Wing with Port Cannula
- Others
Straight cannulas are the most used variants as they are equipped with an extra sharp needle that makes it easier to insert into veins or arteries.
Breakup by Size:
- 14G
- 16G
- 18G
- 20G
- 22G
- 24G
- 26G
18 G cannulas account for the majority of the global cannula market share as they are extensively used in hospitals to infuse products and deliver medications.
Breakup by Material:
- Plastic (PVC) Cannulas
- Silicone Cannulas
- Metal Cannulas (Stainless Steel)
Plastic (PVC) cannulas currently hold the largest market share due to their widespread adoption in both in-patient and out-patient procedures.
Breakup by Application:
- Cardiovascular Surgery
- Oxygen Therapy
- General Surgery
- Cosmetic/Plastic Surgery
- Orthopedic Surgery
- Others
Breakup by End-User:
- Hospitals
- Ambulatory Surgery Centers (ASCs)
- Others
Hospitals presently dominate the market on account of the rising prevalence of chronic medical disorders and increasing accidents and hospitalization rate.
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Related Report: